Cellmid Limited Price Chart
Cellmid Limited CDY.XA Financial and Trading Overview
| Cellmid Limited stock price | 0.06 AUD |
| Previous Close | 0.06 AUD |
| Open | 0.06 AUD |
| Bid | 0.06 AUD x N/A |
| Ask | 0.06 AUD x N/A |
| Day's Range | 0.06 - 0.06 AUD |
| 52 Week Range | 0.06 - 0.06 AUD |
| Volume | 47.84K AUD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | -1.434975 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CDY.XA Valuation Measures
| Enterprise Value | 5.2M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1 |
| Enterprise Value/Revenue | 0.894 |
| Enterprise Value/EBITDA | -1.681 |
Trading Information
Cellmid Limited Stock Price History
| Beta (5Y Monthly) | -1.434975 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.06 AUD |
| 52 Week Low | 0.06 AUD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
CDY.XA Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 105.87M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2021 |
| Most Recent Quarter (mrq) | June 30, 2021 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -58.22% |
| Operating Margin (ttm) | -55.92% |
| Gross Margin | 63.67% |
| EBITDA Margin | -53.20% |
Management Effectiveness
| Return on Assets (ttm) | -14.42% |
| Return on Equity (ttm) | -37.58% |
Income Statement
| Revenue (ttm) | 5.82M AUD |
| Revenue Per Share (ttm) | 0.04 AUD |
| Quarterly Revenue Growth (yoy) | -17.89% |
| Gross Profit (ttm) | 3.7M AUD |
| EBITDA | -3094679 AUD |
| Net Income Avi to Common (ttm) | -3804934 AUD |
| Diluted EPS (ttm) | -0.024 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.73M AUD |
| Total Cash Per Share (mrq) | 0.04 AUD |
| Total Debt (mrq) | 1.43M AUD |
| Total Debt/Equity (mrq) | 13.74 AUD |
| Current Ratio (mrq) | 5.894 |
| Book Value Per Share (mrq) | 0.056 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4114150 AUD |
| Levered Free Cash Flow (ttm) | -3076227 AUD |
Profile of Cellmid Limited
| Country | Australia |
| State | NSW |
| City | Sydney |
| Address | 55 Clarence Street |
| ZIP | 2000 |
| Phone | 61 2 9221 6830 |
| Website | https://cellmid.com.au |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Cellmid Limited, a consumer health company, develops, manufactures, and markets anti-aging products for hair, skin, and wellbeing in Australia, the United States, China, and Japan. It develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. In addition, the company markets its products through retailers and wholesalers, as well as through a direct-to-consumer, e-commerce platform. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.
Q&A For Cellmid Limited Stock
What is a current CDY.XA stock price?
Cellmid Limited CDY.XA stock price today per share is 0.06 AUD.
How to purchase Cellmid Limited stock?
You can buy CDY.XA shares on the CXA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cellmid Limited?
The stock symbol or ticker of Cellmid Limited is CDY.XA.
How many shares does Cellmid Limited have in circulation?
The max supply of Cellmid Limited shares is 0.
What is Cellmid Limited Price to Earnings Ratio (PE Ratio)?
Cellmid Limited PE Ratio is 0.00000000 now.
What was Cellmid Limited earnings per share over the trailing 12 months (TTM)?
Cellmid Limited EPS is 0 AUD over the trailing 12 months.